Accessibility/Mobile Features
Skip Navigation
Skip to Content
Editorial News
Business
Classified Sites

The Canadian Press - ONLINE EDITION

Valeant Pharmaceuticals to sell some assets to Nestle For $1.4 billion

LAVAL, Que. - Valeant Pharmaceuticals International, Inc. ((TSX:VRX) says it has agreed to sell the rights to five products to Nestle S.A. for $1.4 billion.

Laval, Que.-based Valeant says Nestle expects to complete its acquisition of Galderma S.A. in July and would expect to operate the acquired assets through Galderma.

The transaction is subject to customary closing conditions and Valeant says it is not contingent upon a successful transaction with Botox-maker Allergan, Inc.

Valeant has made a hostile takeover offer for California-based Allergan, which fired back Tuesday by saying Valeant's growth is overstated and questioned its ability to cut US$2.7 billion of expenses if it acquires the company.

The broadside came ahead of what is expected to be an improved offer from Valeant on Wednesday.

"We are pleased to enter into this transaction," said Valeant chairman and CEO J. Michael Pearson, adding Galderma is "firmly committed to the aesthetic dermatology."

The five anti-aging skin treatments being sold by Valeant are Restylane, Perlane, Emervel, Sculptra and Dysport.

  • Rate this Rate This Star Icon
  • This article has not yet been rated.
  • We want you to tell us what you think of our articles. If the story moves you, compels you to act or tells you something you didn’t know, mark it high. If you thought it was well written, do the same. If it doesn’t meet your standards, mark it accordingly.

    You can also register and/or login to the site and join the conversation by leaving a comment.

    Rate it yourself by rolling over the stars and clicking when you reach your desired rating. We want you to tell us what you think of our articles. If the story moves you, compels you to act or tells you something you didn’t know, mark it high.

Sort by: Newest to Oldest | Oldest to Newest | Most Popular 0 Commentscomment icon

You can comment on most stories on brandonsun.com. You can also agree or disagree with other comments. All you need to do is register and/or login and you can join the conversation and give your feedback.

There are no comments at the moment. Be the first to post a comment below.

Post Your Commentcomment icon

Comment
  • You have characters left

The Brandon Sun does not necessarily endorse any of the views posted. Comments are moderated before publication. By submitting your comment, you agree to our Terms and Conditions. New to commenting? Check out our Frequently Asked Questions.

letters

Make text: Larger | Smaller

Brandon Sun Business Directory
Sudden Surge: Flood of 2014
Opportunity Magazine — The Bakken
Why Not Minot?
Welcome to Winnipeg

Social Media

Canadian Mortgage Rates